Webinars and Events

Date Event and Location
April 30-May 2, 2018
Rotterdam

The emerging field of precision cancer medicine, in which the use of molecular data at the point of care directly impacts patient treatment and clinical decision-making, has already had a substantial, direct clinical impact on many aspects of medical oncology. The introduction of large-scale genomic technologies at the point of care has catalyzed discoveries in translational oncology and is driving new research that aims to dissect selective responses to targeted, immune-driven therapies and to chemotherapies, as well as identifying novel targets for which therapies are now in development. However, precision cancer medicine remains a promise rather than a solid and robust reality. Although the molecular landscapes of many cancers have been revealed using precision oncology approaches, many of the alterations observed in patients remain undruggable, and viable targets are incompletely characterized. In this conference we will discuss and address current advances, challenges and ignite solutions for the advancement of precision medicine.
May 3-5, 2018
Montpellier, France

The 2018 meeting in Montpellier is organized together with the established EU-IMI consortium CANCER-ID and brings together basic and clinical researchers from academia and companies.
May 6-9, 2018
West Palm Beach, FL

The ASM Clinical Virology Symposium will be held May 6–9, 2018, in its new location at the Palm Beach County Convention Center in West Palm Beach, Florida! Led by biomedical scientists engaged in research as well as primary care physicians and laboratorians involved with patient care, this international symposium will provide an unmatched forum for the meaningful exchange of ideas dealing with viral infections.
May 22-April 24, 2018
Lisbon, Portugal

Cambridge Healthtech Institute’s Sixth International Molecular Diagnostics Europe event will return to Lisbon on 22-24 May 2018. This meeting provides a nexus for diagnostic developers in academia and industry as well as end-users in the pharmaceutical and healthcare sector to gain a comprehensive picture of molecular diagnostics in prenatal, oncology, infectious disease, point-of-care, and liquid biopsy.
June 16-19, 2018
Düsseldorf, Germany

The excellent programme committee will be selecting the best speakers and presentations which together with other highlights will ensure that the 2018 conference will continue to build on the success of the 50th anniversary conference. The ESHG will be taking the first step for (hopefully) the next 50 years and delivering a conference showcasing the latest findings in the field of human genetics, both basic and applied.